Pfizer Stock (PFE) Falls on 2026 Sales Outlook as Cancer Drugs Fuel Q2 Beat
Pfizer’s ($PFE) shares edged lower during Tuesday’s pre-market session after the U.S. pharma giant raised its full-year 2026 sales outlook but stil...
Pfizer Inc (PFE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 109,067,291 | $2,626,340,379 | +4% | 0.78% |
| 2. | Walleye Capital Will England | 2,417,136 | $58,204,635 | +126% | 0.21% |
| 3. | 1,081,000 | $26,030,480 | +202% | 0.09% | |
| 4. | Bourgeon Capital John Zaro | 372,849 | $8,978,204 | +5% | 1.32% |
| 5. | Hourglass Capital Kenneth A. Moffet | 357,348 | $8,604,940 | +3% | 1.69% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.46 | 39,231 | $998,821.26 | 66,938 | 2026-08-05 | Filing | |
| $25.52 | 37,632 | $960,368.64 | 37,632 | 2026-08-05 | Filing | |
| $25.65 | 19,457 | $499,072.05 | 27,707 | 2025-02-13 | Filing | |
| $28.24 | 1,000 | $28,240.00 | 10,000 | 2024-10-30 | Filing | |
| $26.47 | 3,000 | $79,401.00 | 9,000 | 2023-12-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.70 | 2,000 | $51,400.00 | 31,397 | 2026-06-09 | Filing | |
| $25.93 | 2,500 | $64,825.00 | 11,850 | 2025-03-04 | Filing | |
| $28.66 | 5,154 | $147,713.64 | 8,582 | 2024-08-13 | Filing | |
| $40.02 | 9,912 | $396,678.24 | 9,003 | 2023-03-15 | Filing | |
| $53.96 | 4,218 | $227,603.28 | 10,846 | 2022-06-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 56,551,011 | $1,381,020,334 | 0.44% | |
| 2. | 19,228,115 | $463,013,015 | 0.15% | |
| 3. | 13,775,929 | $331,724,370 | 0.19% | |
| 4. | 11,918,197 | $286,990,186 | 0.35% | |
| 5. | 11,902,374 | $286,609,166 | 0.36% |
News See All
Options Volatility and Implied Earnings Moves Today, August 04, 2026
Today, several major companies are expected to report earnings: Advanced Micro Devices (AMD), Caterpillar (CAT), Energy Transfer (ET), Gilead Scien...
These Are the Stocks Reporting Earnings Today – August 4, 2026
Here’s a look at today’s most important earnings reports from major publicly traded companies. Investors will be watching closely for revenue and p...
Options Volatility and Implied Earnings Moves This Week, August 03 – August 06, 2026
This week, several major companies will be reporting earnings. Among them are Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Walt Disn...
Pfizer Inc. (PFE) vs. Eli Lilly and Company (LLY): The Growth vs. Value Play in Pharma
Pfizer (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) offer unique divergent investment opportunities in the pharmaceutical industry.
Big Pharma Is Buying Growth. Novartis (NVS) Is Betting on Its Pipeline
Biotech M&A has hit a record pace in 2026, with deal value reaching $216 billion so far this year, up from $118 billion over the same stretch last year, according to LSEG data.
8 Worst Blue Chip Stocks to Buy Now
The word “worst” here is not about business quality.
Jim Cramer’s Opinion on 14 Stocks Like Applied Aerospace and Delta Air Lines
In this article, we will look at the stocks Jim Cramer shared his opinions on during Mad Money.
Are Dividend Stocks Tax-Efficient? 10 Picks by the Financial Media
Dividend stocks can be tax-efficient, but only in a qualified sense.
10 Best Dividend Stocks Yielding at Least 5% to Buy According to Hedge Funds
Expect strong market gains heading into the second half of the year. It is a sentiment echoed by research firms on Wall Street in the aftermath of the de-escalation of tensions in the Middle East.
Hedge Fund Resource Center